DUBLIN--(BUSINESS WIRE)--
Research and Markets has announced the addition of the "Hand, Foot and Mouth Disease - Pipeline Review, H2 2016" report to their offering.
Hand, Foot and Mouth Disease - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I and Preclinical stages are 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 2 molecules, respectively. Hand, Foot and Mouth Disease.
Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/3z9d7h/hand_foot_and

View source version on businesswire.com: http://www.businesswire.com/news/home/20161209005464/en/